Add Company
Join Now

Belmar Pharma Solutions Revenue and Competitors

License our Company Data API

Golden, CO USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Belmar Pharma Solutions's estimated annual revenue is currently $25.3M per year.(i)
  • Belmar Pharma Solutions's estimated revenue per employee is $146,393

Employee Data

  • Belmar Pharma Solutions has 173 Employees.(i)
  • Belmar Pharma Solutions grew their employee count by 30% last year.

Belmar Pharma Solutions's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Product ManagementReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
Director Marketing and Corporate CommunicationsReveal Email/Phone
5
Director Midwest OperationsReveal Email/Phone
6
Director Corporate Human ResourcesReveal Email/Phone
7
Clinical Director Women's HealthReveal Email/Phone
8
Director ComplianceReveal Email/Phone
9
Chief Information OfficerReveal Email/Phone
10
Chief Growth OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M250%N/AN/A
#2
$10.3M40-5%N/AN/A
#3
$4.4M14-22%N/AN/A
#4
$195M1220%$121.4MN/A
#5
$4.8M24-20%N/AN/A
#6
$6.8M24-14%N/AN/A
#7
$4.8M2420%N/AN/A
#8
$4M40-11%$138MN/A
#9
$4.8M18-10%N/AN/A
#10
N/A8222%N/AN/A
Add Company

What Is Belmar Pharma Solutions?

Since 1985, Belmar Pharmacy has specialized in compounded oral, sublingual and topical dosage forms. What sets us apart is our unique BLAâ„¢ (Bioavailable Lymphatic Absorption) lipid matrix tablet system designed for oral HRT; our exclusive paraben-free, petroleum-free hormone cream base; and our outstanding customer service and value. Our goal is better patient outcomes, through quality compounding, and effective communication between practitioner, pharmacist and patient.

keywords:N/A

N/A

Total Funding

173

Number of Employees

$25.3M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26.8M1747%N/A
#2
$49.7M18021%N/A
#3
$35M1827%N/A
#4
$15M2080%N/A
#5
$49.9M2174%N/A